1. Clinical Overview
A fixed-dose combination (FDC) medication used primarily for the treatment of lymphatic filariasis (elephantiasis) and associated allergic manifestations. Diethylcarbamazine (DEC) is an anthelmintic and antiparasitic agent effective against microfilariae and adult worms of Wuchereria bancrofti and Brugia malayi. Levocetirizine is a potent, selective second-generation H1-receptor antagonist (antihistamine) that alleviates allergic symptoms like pruritus, urticaria, and angioedema often associated with filarial infections. This combination addresses both the parasitic cause and the inflammatory/allergic symptoms.
| Onset | Duration | Bioavailability |
|---|---|---|
| Levocetirizine: ~1 hour. Diethylcarbamazine: Parasite death begins within hours, but symptomatic relief of allergic symptoms may be seen within 1-2 days. | Levocetirizine: Up to 24 hours. Diethylcarbamazine: The microfilaricidal effect is sustained over the treatment course; pharmacokinetic half-life is short. | Levocetirizine: >85%. Diethylcarbamazine: Rapid and nearly complete (>90%). |
2. Mechanism of Action
Diethylcarbamazine immobilizes microfilariae by altering their surface membranes, making them susceptible to host phagocytosis. It also damages adult worms. Its mechanism may involve inhibition of arachidonic acid metabolism in parasites. Levocetirizine competitively inhibits histamine at the H1 receptor, preventing capillary dilation, bronchoconstriction, and pruritus associated with histamine release during filarial antigen exposure (Mazzotti-like reaction).
3. Indications & Uses
- Lymphatic Filariasis (caused by Wuchereria bancrofti or Brugia malayi)
- Treatment of Bancroftian and Brugian filariasis with associated allergic symptoms
4. Dosage & Administration
Adult Dosage: One tablet (Diethylcarbamazine 300mg + Levocetirizine 5mg) once daily after meals. For filariasis: Typically prescribed for 7-21 days as per physician's advice.
Administration: Take after food to minimize gastrointestinal upset. Swallow whole with a glass of water. Do not crush or chew. Evening administration may help with compliance and manage nocturnal symptoms. Complete the full course as prescribed.
5. Side Effects
Common side effects may include:
- Headache
- Dizziness
- Drowsiness/sedation (less with levocetirizine)
- Nausea, vomiting
- Abdominal pain
- Loss of appetite
- Fatigue
- Dry mouth
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| CNS Depressants (Alcohol, Benzodiazepines, Opioids) | Additive sedative effect with levocetirizine. | Major |
| Theophylline | May reduce the clearance of levocetirizine slightly. | Moderate |
| Ritonavir | May increase levocetirizine levels. | Moderate |
| Drugs causing QT prolongation (e.g., Erythromycin, antipsychotics) | Theoretical additive risk of QT prolongation. | Moderate |
| Nephrotoxic drugs (Aminoglycosides, NSAIDs) | May worsen renal function, affecting levocetirizine excretion. | Moderate |
7. Patient Counselling
- DO take the tablet after food.
- DO complete the full course of treatment even if you feel better.
- DO inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.
- DO inform your doctor about all other medicines you are taking.
- DONT consume alcohol while on this medication.
- DONT drive or operate heavy machinery until you know how the medicine affects you.
- DONT take a double dose to make up for a missed one.
8. Toxicology & Storage
Overdose: Diethylcarbamazine: Nausea, vomiting, dizziness, headache, hypotension, confusion. Levocetirizine: Drowsiness, agitation, restlessness, tachycardia, urinary retention. Combined: Profound sedation, CNS depression, cardiorespiratory compromise.
Storage: Store below 30°C. Protect from light and moisture. Keep in the original blister pack or container. Keep out of reach of children.